Skip to Content

3,907 Results Found

  • Article
  • Open Access
164 Views
13 Pages

Lower Dexamethasone Dose in Multiple Myeloma: A Multicenter Retrospective Analysis

  • Lili Korpás,
  • Ádám Wiedemann,
  • Fruzsina Szél,
  • Szabolcs Svorenj and ,
  • Júlia Weisinger,
  • Zsolt Nagy,
  • Zsuzsanna Szemlaky,
  • Zoltán Csukly,
  • Péter Reményi and
  • Gergely Varga
  • + 19 authors+ 14 authors

6 November 2026

Background/Objectives: Dexamethasone has long served as the cornerstone of therapy for multiple myeloma; however, its optimal dosing remains ill-defined, particularly when balanced against its profound toxicity profile. Recent therapeutic advances ha...

(This article belongs to the Special Issue Clinical Trials and Translational Research in Multiple Myeloma)
  • Article
  • Open Access
2 Citations
3,264 Views
13 Pages

Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma

  • Kazuhito Suzuki,
  • Tadahiro Gunji,
  • Masaharu Kawashima,
  • Hideki Uryu and ,
  • Riku Nagao,
  • Takeshi Saito,
  • Kaichi Nishiwaki and
  • Shingo Yano
  • + 3 authors+ 0 author

30 January 2025

Background: Daratumumab (DARA), lenalidomide (LEN), and dexamethasone (DEX, DRd) are one of standards of care for patients with multiple myeloma (MM); however, the clinical impact of relative dose intensity (RDI) remains unclear. In this retrospectiv...

(This article belongs to the Special Issue Pathogenesis and Treatment Strategies in Multiple Myeloma: From Basic Research to Real Life)
  • Article
  • Open Access
797 Views
13 Pages

16 April 2026

Background/Objectives: LINAC-based, single-isocenter, non-coplanar, stereotactic radiotherapy (SRT) is an effective treatment for patients with multiple brain metastases (BMs). Within such a treatment plan, individual beams can be assigned to treat a...

(This article belongs to the Section Cancer Metastasis)
  • Article
  • Open Access
2,366 Views
12 Pages

Trabecular Attenuation of L1 in Adult Patients with Multiple Myeloma: An Observational Study on Low-Dose CT Images

  • Carlo Augusto Mallio,
  • Valeria Tomarchio,
  • Francesco Pulcini,
  • Edoardo Verducci and ,
  • Caterina Bernetti,
  • Maria Antonietta Tafuri,
  • Federico Greco,
  • Luigi Rigacci,
  • Bruno Beomonte Zobel and
  • Ombretta Annibali
  • + 5 authors+ 0 author

17 October 2024

Background: The aim of this study was to evaluate the impact of trabecular attenuation of the L1 vertebral body in low-dose CT in adult patients with multiple myeloma (MM), smoldering multiple myeloma (SMM), and monoclonal gammopathy of undetermined...

  • Review
  • Open Access
12 Citations
14,031 Views
17 Pages

Whole-Body Low-Dose Multidetector-Row CT in Multiple Myeloma: Guidance in Performing, Observing, and Interpreting the Imaging Findings

  • Antonio Pierro,
  • Alessandro Posa,
  • Costanzo Astore,
  • Mariacarmela Sciandra and ,
  • Alessandro Tanzilli,
  • Antonella Petrosino,
  • Maria Saveria del Balso,
  • Vincenzo Fraticelli,
  • Savino Cilla and
  • Roberto Iezzi
  • + 5 authors+ 0 author

30 November 2021

Multiple myeloma is a hematological malignancy of plasma cells usually detected due to various bone abnormalities on imaging and rare extraosseous abnormalities. The traditional approach for disease detection was based on plain radiographs, showing t...

(This article belongs to the Section Medical Research)
  • Article
  • Open Access
5 Citations
6,099 Views
12 Pages

Prescribed Total Daily Insulin Dose and Predictors of Insulin Dose for Adults with Type 2 Diabetes on Multiple Daily Injections of Insulin: A Retrospective Cohort Study

  • Eugene E. Wright, Jr.,
  • Viral N. Shah,
  • Eden Miller,
  • Andrew Thach and ,
  • Pasha Javadi,
  • Shawn Davies and
  • Ray Sieradzan
  • + 2 authors+ 0 author

Background/Objectives: Limited evidence is available regarding insulin total daily dose (TDD), or the factors associated with TDD, among adults with type 2 diabetes (T2D) using multiple daily injections of insulin (MDI). Our aim was to determine the...

  • Article
  • Open Access
46 Citations
5,924 Views
18 Pages

Erythrocyte Encapsulated Thymidine Phosphorylase for the Treatment of Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy: Study Protocol for a Multi-Centre, Multiple Dose, Open Label Trial

  • Bridget E. Bax,
  • Michelle Levene,
  • Murray D. Bain,
  • Lynette D. Fairbanks and ,
  • Massimiliano Filosto,
  • Sema Kalkan Uçar,
  • Thomas Klopstock,
  • Cornelia Kornblum,
  • Hanna Mandel and
  • Niranjanan Nirmalananthan
  • + 13 authors+ 8 authors

24 July 2019

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disorder which primarily affects the gastrointestinal and nervous systems. This disease is caused by mutations in the nuclear TYMP gene, which encodes for thymidi...

(This article belongs to the Section Clinical Neurology)
  • Article
  • Open Access
23 Citations
1,678 Views
8 Pages

1 February 2013

Background: A growing body of evidence is demonstrating that the nitrogen-containing bisphosphonate zoledronic acid (zol) improves clinical outcomes in various cancer settings, including multiple myeloma. Those findings provided the rationale for con...

  • Article
  • Open Access
3 Citations
3,076 Views
15 Pages

Physiological Responses to Multiple Low-Doses of Bacillus anthracis Spores in the Rabbit Model of Inhalation Anthrax

  • Sarah C. Taft,
  • Tonya L. Nichols,
  • Stephanie A. Hines,
  • Roy E. Barnewall and ,
  • Gregory V. Stark and
  • Jason E. Comer
  • + 1 author+ 0 author

24 October 2020

Bacillus anthracis spores that are re-aerosolized from surface deposits after initial contamination present significant health risks for personnel involved in decontamination. To model repeated exposure to low dose B. anthracis spores, three groups o...

  • Article
  • Open Access
15 Citations
5,848 Views
16 Pages

Dosimetric Impact of Lesion Number, Size, and Volume on Mean Brain Dose with Stereotactic Radiosurgery for Multiple Brain Metastases

  • Alonso La Rosa,
  • D Jay J. Wieczorek,
  • Ranjini Tolakanahalli,
  • Yongsook C. Lee and ,
  • Tugce Kutuk,
  • Martin C. Tom,
  • Matthew D. Hall,
  • Michael W. McDermott,
  • Minesh P. Mehta and
  • Rupesh Kotecha
  • + 6 authors+ 1 author

27 January 2023

We evaluated the effect of lesion number and volume for brain metastasis treated with SRS using GammaKnife® ICON™ (GK) and CyberKnife® M6™ (CK). Four sets of lesion sizes (<5 mm, 5–10 mm, >10–15 mm, and >15 mm...

(This article belongs to the Special Issue Advances in Stereotactic Radiotherapy of Brain Metastases)
  • Article
  • Open Access
3 Citations
2,687 Views
10 Pages

Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis

  • Giorgia Teresa Maniscalco,
  • Daniele Di Giulio Cesare,
  • Valerio Liguori,
  • Valentino Manzo and ,
  • Elio Prestipino,
  • Simona Salvatore,
  • Maria Elena Di Battista,
  • Ornella Moreggia,
  • Antonio Rosario Ziello and
  • Annalisa Capuano
  • + 7 authors+ 2 authors

23 June 2023

Since the beginning of the mass immunization of patients with multiple sclerosis (MS), many data on the efficacy and safety of COVID-19 vaccines have been produced. Considering that MS is an autoimmune disease and that some disease-modifying therapie...

(This article belongs to the Special Issue Medication Safety and Pharmacovigilance in Clinical: From the Researcher Bench to the Patient Bedside)
  • Review
  • Open Access
11 Citations
10,583 Views
11 Pages

Background: Methicillin-susceptible Staphylococcus aureus (MSSA) is a common pathogen associated with a range of clinically important infections. MSSA can cause deep-seated infections requiring prolonged courses of intravenous antibiotic therapy to a...

(This article belongs to the Special Issue Methicillin-Resistant Staphylococci)
  • Article
  • Open Access
16 Citations
5,465 Views
14 Pages

Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World Experience

  • Martina Nasello,
  • Valeria Zancan,
  • Virginia Rinaldi,
  • Antonio Marrone and ,
  • Roberta Reniè,
  • Selene Diamant,
  • Martina Marconi,
  • Lorenzo Le Mura,
  • Marco Salvetti and
  • Gianmarco Bellucci
  • + 6 authors+ 1 author

Ocrelizumab (OCR), an anti-CD20 monoclonal antibody, is approved for treating relapsing remitting (RR) and primary progressive (PP) multiple sclerosis (MS). The standard interval dosing (SID) regimen requires intravenous infusions every six months. E...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
20 Citations
6,645 Views
23 Pages

8 February 2021

The authors in the current work suggested the potential repurposing of omarigliptin (OMR) for neurodegenerative diseases based on three new findings that support the preliminary finding of crossing BBB after a single dose study in the literature. The...

(This article belongs to the Special Issue Analysis of Drugs in Biological Samples through Liquid Chromatography)
  • Article
  • Open Access
3 Citations
2,362 Views
19 Pages

Depletion of Albendazole and Its Metabolites and Their Impact on the Gut Microbial Community Following Multiple Oral Dosing in Yellow River Carp (Cyprinus carpio haematopterus)

  • Yue Liu,
  • Yan Dai,
  • Yan-Ni Zhang,
  • Wen-Rui Wang and ,
  • Yu-Xin Chen,
  • Yang-Guang Jin,
  • Long-Ji Sun,
  • Shi-Hao Li,
  • Fang Yang and
  • Fan Yang
  • + 6 authors+ 1 author

14 August 2025

Healthy Yellow River carp (Cyprinus carpio haematopterus) reared at a water temperature of 23 ± 0.6 °C were orally administered albendazole (ABZ) at a dose of 12 mg/kg body weight (BW) once daily for seven consecutive days. At predetermine...

(This article belongs to the Section Welfare, Health and Disease)
  • Article
  • Open Access
45 Citations
6,066 Views
18 Pages

The Efficacy of Amifostine against Multiple-Dose Doxorubicin-Induced Toxicity in Rats

  • Vesna Jaćević,
  • Viktorija Dragojević-Simić,
  • Željka Tatomirović,
  • Silva Dobrić and ,
  • Dubravko Bokonjić,
  • Aleksandra Kovačević,
  • Eugenie Nepovimova,
  • Martin Vališ and
  • Kamil Kuča
  • + 4 authors+ 0 author

Amifostine is well known cytoprotector which is efficient when administered before a wide range of antineoplastic agents. The aim of our study was to investigate amifostine effects on doxorubicin-induced toxic changes in rats. Amifostine (75 mg/kg ip...

(This article belongs to the Special Issue Frontiers in Drug Toxicity Prediction)
  • Review
  • Open Access
5 Citations
4,472 Views
10 Pages

Comparison between Multiple Doses and Single-Dose Steroids in Preventing the Incidence of Reintubation after Extubation among Critically Ill Patients: A Network Meta-Analysis

  • Chiwon Ahn,
  • Min Kyun Na,
  • Kyu-Sun Choi,
  • Tae Ho Lim and ,
  • Bo-Hyoung Jang,
  • Wonhee Kim,
  • Youngsuk Cho,
  • Hyungoo Shin,
  • Jae Guk Kim and
  • Juncheol Lee
  • + 5 authors+ 0 author

29 June 2021

This study aimed to determine the frequency of prophylactic steroid administration to prevent reintubation after extubation in critically ill patients. We systematically searched MEDLINE, Embase and Cochrane Library for studies regarding the preventi...

(This article belongs to the Section Intensive Care)
  • Article
  • Open Access
15 Citations
4,854 Views
13 Pages

14 December 2023

The aim of this study was to compare the pharmacokinetics of oxytetracycline (OTC) following single- (60 mg/kg) and multiple-dose oral administrations (60 mg/kg, every 24 h for 7 days) in rainbow trout. It also aimed to determine bioavailability afte...

(This article belongs to the Section Animal System and Management)
  • Article
  • Open Access
44 Citations
10,640 Views
12 Pages

The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients

  • Matías Sáenz-Cuesta,
  • Ainhoa Alberro,
  • Maider Muñoz-Culla,
  • Iñaki Osorio-Querejeta and ,
  • Marta Fernandez-Mercado,
  • Itziar Lopetegui,
  • Mikel Tainta,
  • Álvaro Prada,
  • Tamara Castillo-Triviño and
  • David Otaegui
  • + 7 authors+ 2 authors

Extracellular vesicles (EVs) are membrane-bound particles involved in intercellular communication. They carry proteins, lipids, and nucleotides such as microRNAs (miRNAs) from the secreting cell that can modulate target cells. We and others have prev...

(This article belongs to the Special Issue Focus on Exosome-Based Cell-Cell Communication in Health and Disease)
  • Article
  • Open Access
30 Citations
6,464 Views
20 Pages

Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells

  • Claire Gourzones,
  • Céline Bellanger,
  • Sylvain Lamure,
  • Ouissem Karmous Gadacha and ,
  • Elvira Garcia De Paco,
  • Laure Vincent,
  • Guillaume Cartron,
  • Bernard Klein and
  • Jérôme Moreaux
  • + 4 authors+ 0 author

28 March 2019

Background: Multiple myeloma (MM) is the second most common hematological cancer after lymphoma. It is characterized by the accumulation of clonal malignant plasma cells within the bone marrow. The development of drug resistance remains a major probl...

(This article belongs to the Special Issue Cancer Chemoresistance)
  • Article
  • Open Access
3 Citations
4,007 Views
12 Pages

Confirmation of CD19+ B-Lymphocyte Depletion Prior to Intake of the Second Dose of Ocrelizumab in Multiple Sclerosis Patients

  • Marija Radmilo,
  • Sanda Pavelin,
  • Igor Vujović,
  • Joško Šoda and
  • Maja Rogić Vidaković

The aim of the retrospective study was to compare the immunophenotyping of T-lymphocytes, B-lymphocytes, and natural killer cells before the administration of the first and the second dose of ocrelizumab in 22 patients with multiple sclerosis in a th...

(This article belongs to the Section Neurobiology and Clinical Neuroscience)
  • Article
  • Open Access
1 Citations
3,740 Views
22 Pages

Pharmacokinetics, Dose-Proportionality, and Tolerability of Intravenous Tanespimycin (17-AAG) in Single and Multiple Doses in Dogs: A Potential Novel Treatment for Canine Visceral Leishmaniasis

  • Marcos Ferrante,
  • Bruna Martins Macedo Leite,
  • Lívia Brito Coelho Fontes,
  • Alice Santos Moreira and ,
  • Élder Muller Nascimento de Almeida,
  • Claudia Ida Brodskyn,
  • Isadora dos Santos Lima,
  • Washington Luís Conrado dos Santos,
  • Luciano Vasconcellos Pacheco and
  • Patrícia Sampaio Tavares Veras
  • + 12 authors+ 7 authors

In the New World, dogs are considered the main reservoir of visceral leishmaniasis (VL). Due to inefficacies in existing treatments and the lack of an efficient vaccine, dog culling is one of the main strategies used to control disease, making the de...

(This article belongs to the Special Issue Recent Advancements in the Development of Antiprotozoal Agents)
  • Article
  • Open Access
14 Citations
4,201 Views
14 Pages

Platelet Inhibition by Low-Dose Acetylsalicylic Acid Reduces Neuroinflammation in an Animal Model of Multiple Sclerosis

  • Anna Vogelsang,
  • Susann Eichler,
  • Niklas Huntemann,
  • Lars Masanneck and ,
  • Hannes Böhnlein,
  • Lisa Schüngel,
  • Alice Willison,
  • Karin Loser,
  • Bernhard Nieswandt and
  • Sven G. Meuth
  • + 8 authors+ 3 authors

14 September 2021

Aside from the established immune-mediated etiology of multiple sclerosis (MS), compelling evidence implicates platelets as important players in disease pathogenesis. Specifically, numerous studies have highlighted that activated platelets promote th...

(This article belongs to the Special Issue Multiple Sclerosis and Demyelinating Pathologies: Mechanisms and Cutting-Edge Therapies)
  • Systematic Review
  • Open Access
3 Citations
1,934 Views
13 Pages

The Role of Biological Effective Dose in Gamma Knife Radiosurgery: A Systematic Review Across Multiple Indications

  • Hao Deng,
  • Xinyuejia Huang,
  • Qian Wang,
  • Yuan Gao and ,
  • Mengqi Wang,
  • Yang Wu,
  • Xiaoman Shi,
  • Maoyu Wang,
  • Wei Pan and
  • Wei Wang
  • + 6 authors+ 1 author

5 January 2026

Background: Gamma Knife radiosurgery (GKS) is widely used for the management of intracranial disorders. Emerging evidence suggests that incorporating the biological effective dose (BED) into GKS planning may improve the prediction of treatment effica...

(This article belongs to the Section Nuclear Medicine & Radiology)
  • Article
  • Open Access
3 Citations
10,523 Views
16 Pages

Perception of Quality of Life and Fatigue in Multiple Sclerosis Patients Treated with High-Dose Vitamin D

  • Antonio Ianniello,
  • Andrea Sottosanti,
  • Giovanna Borriello and
  • Massimo Vincenti

Background: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system, with symptoms that greatly affect quality of life (QoL). One of the most prevalent symptoms of MS is fatigue, also one of the main factors reducing QoL...

  • Article
  • Open Access
3 Citations
1,781 Views
15 Pages

Gender-Specific Prognostic Impact of Treosulfan Levels in High-Dose Chemotherapy for Multiple Myeloma

  • Alexander D. Heini,
  • Karin Kammermann,
  • Ulrike Bacher,
  • Barbara Jeker and ,
  • Michael Hayoz,
  • Yolanda Aebi,
  • Carlo R. Largiadèr,
  • Henning Nilius and
  • Thomas Pabst
  • + 4 authors+ 0 author

1 October 2024

Introduction: The growing body of evidence around sexual and gender dimorphism in medicine, particularly in oncology, has highlighted differences in treatment response, outcomes, and side effects between males and females. Differences in drug metabol...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
3 Citations
2,525 Views
9 Pages

Correlation of Nabiximols Dose to Steady-State Concentrations of Cannabinoids in Urine Samples from Patients with Multiple Sclerosis

  • Rüdiger Birke,
  • Stefanie Meister,
  • Alexander Winkelmann,
  • Burkhard Hinz and
  • Udo I. Walther

27 June 2022

Therapeutic drug monitoring of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) is based on a complex procedure and is therefore not possible in most laboratories, especially in emergency cases. This work addresses the question of whether th...

(This article belongs to the Section Clinical Neurology)
  • Article
  • Open Access
11 Citations
3,457 Views
16 Pages

Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma

  • Cédric Gillich,
  • Dilara Akhoundova,
  • Michael Hayoz,
  • Yolanda Aebi and ,
  • Carlo R. Largiadèr,
  • Katja Seipel,
  • Michael Daskalakis,
  • Ulrike Bacher and
  • Thomas Pabst
  • + 4 authors+ 0 author

10 May 2023

(1) Background: Upfront treatment consolidation with high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) has relevantly contributed to achieving durable remissions following induction treatment in multiple myeloma (MM) patie...

(This article belongs to the Special Issue Latest Development in Multiple Myeloma)
  • Article
  • Open Access
5 Citations
3,079 Views
18 Pages

We investigated the age-related effects of the lipid-lowering drug fenofibrate on renal stress-associated effectors. Young and old rats were fed standard chow with 0.1% or 0.5% fenofibrate. The kidney cortex tissue structure showed typical aging-rela...

(This article belongs to the Special Issue Molecular Mechanisms of the Aging Process)
  • Article
  • Open Access
5 Citations
3,229 Views
19 Pages

Comparison of Repeated Doses of C-kit-Positive Cardiac Cells versus a Single Equivalent Combined Dose in a Murine Model of Chronic Ischemic Cardiomyopathy

  • Qianhong Li,
  • Yiru Guo,
  • Yibing Nong,
  • Alex Tomlin and ,
  • Anna Gumpert,
  • Xiaoping Zhu,
  • Syed Adeel Hassan and
  • Roberto Bolli
  • + 3 authors+ 0 author

Using a murine model of chronic ischemic cardiomyopathy caused by an old myocardial infarction (MI), we have previously found that three doses of 1 × 106 c-kit positive cardiac cells (CPCs) are more effective than a single dose of 1 × 106 cells. The...

(This article belongs to the Special Issue Cardiac Repair and Regeneration: New Molecular Mechanisms and Therapeutics)
  • Article
  • Open Access
1,786 Views
18 Pages

High-Dose Ethanol-Induced Immunosuppression Modulates Sex-Specific Disease Outcomes in a Murine Model of Multiple Sclerosis

  • Adriana S. P. Nuncio,
  • Katherine Motovilov,
  • Max Weed,
  • Simali Shah and ,
  • Sam Bazzi,
  • Esha Idnani,
  • Turner Lime,
  • Daniela Carrizales Sauceda,
  • Regina A. Mangieri and
  • Esther Melamed
  • + 6 authors+ 1 author

13 March 2026

Both epidemiological studies and prior work in animal models suggest that moderate-dose alcohol reduces disease severity across several autoimmune conditions, including multiple sclerosis (MS). However, the mechanisms underlying the potentially benef...

(This article belongs to the Special Issue Alcohol-Related Organ Damage: Mechanisms, Outcomes, and Treatment Modalities)
  • Article
  • Open Access
2 Citations
1,005 Views
13 Pages

Balancing Conformity and Low-Dose Brain Exposure Across Gamma Knife and Linac-Based Stereotactic Radiosurgery Techniques for Multiple Brain Metastases

  • Cristina Teixeira,
  • Orbay Askeroğlu,
  • Marlies Boussaer,
  • Sven Van Laere and ,
  • Selçuk Peker,
  • Mark De Ridder and
  • Thierry Gevaert
  • + 2 authors+ 0 author

30 March 2026

Background/Objectives: LINAC-based single-isocenter (SIT) stereotactic radiosurgery (SRS) enables efficient treatment of multiple brain metastases but may compromise target conformity and increase low-dose brain exposure, particularly for spatially d...

(This article belongs to the Special Issue Radiosurgery for Brain Tumors)
  • Review
  • Open Access
10 Citations
8,064 Views
19 Pages

Upholding or Breaking the Law of Superposition in Pharmacokinetics

  • Malaz Yousef,
  • Jaime A. Yáñez,
  • Raimar Löbenberg and
  • Neal M. Davies

The law of superposition underpins first-order linear pharmacokinetic relationships. Most drugs, therefore, after a single dose can be described by first-order or linear processes, which can be superposed to understand multiple-dose regimen behavior....

(This article belongs to the Section Drug Discovery, Development and Delivery)
  • Article
  • Open Access
6 Citations
12,606 Views
11 Pages

A Comparative Pharmacokinetic Study of Fexuprazan 10 mg: Demonstrating Bioequivalence with the Reference Formulation and Evaluating Steady State

  • Wonsuk Shin,
  • A-Young Yang,
  • Hyung Park,
  • Hyejung Lee and ,
  • Hyounggyoon Yoo and
  • Anhye Kim
  • + 1 author+ 0 author

11 August 2023

Fexuprazan is a potassium-competitive acid blocker approved for treating gastric-acid-related diseases. Although the effectiveness of the recent formulation fexuprazan 10 mg has been demonstrated in Phase 3 clinical trials, data on the pharmacokineti...

(This article belongs to the Special Issue Pharmacokinetics (PK)/Pharmacodynamics (PD) Study in Drug Discovery and Development)
  • Article
  • Open Access
5 Citations
3,698 Views
19 Pages

Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab

  • Júlia Granell-Geli,
  • Cristina Izquierdo-Gracia,
  • Ares Sellés-Rius,
  • Aina Teniente-Serra and ,
  • Silvia Presas-Rodríguez,
  • María José Mansilla,
  • Luis Brieva,
  • Javier Sotoca,
  • María Alba Mañé-Martínez and
  • Cristina Ramo-Tello
  • + 9 authors+ 4 authors

10 December 2021

Natalizumab is a monoclonal antibody that binds CD49d. Although it is one of the most effective treatments for Relapsing-Remitting Multiple Sclerosis (RRMS), a dosing regimen has not been optimized for safety and efficacy in individual patients. We a...

(This article belongs to the Special Issue Personalized Diagnosis and Therapy for Multiple Sclerosis)
  • Article
  • Open Access
1 Citations
3,058 Views
10 Pages

Immunotherapy and chemotherapy combinations have proven to be a safe and efficacious treatment approach in multiple settings. However, it is not clear whether approved doses of chemotherapy developed to achieve a maximum tolerated dose are the ideal...

(This article belongs to the Special Issue Bayesian Design in Clinical Trials)
  • Article
  • Open Access
11 Citations
3,448 Views
10 Pages

Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All/Multiple Sites for Oligometastatic Renal Cell Cancer Patients

  • Ming-Wei Ma,
  • Hong-Zhen Li,
  • Xian-Shu Gao,
  • Ming-Zhu Liu and ,
  • Huan Yin,
  • Kai-Wei Yang,
  • Jia-Yan Chen,
  • Xue-Ying Ren and
  • Dian Wang
  • + 4 authors+ 0 author

17 October 2022

Background: Stereotactic ablative body radiotherapy (SABR) is one of the treatment options for oligometastatic renal cell carcinoma (RCC) but is limited by a lack of data to evaluate high-dose SABR to all/multiple sites. Objective: This study retrosp...

(This article belongs to the Section Genitourinary Oncology)
  • Article
  • Open Access
6 Citations
2,856 Views
15 Pages

COVID-19 Vaccination Coverage and Associated Factors in Patients with Multiple Sclerosis

  • Ignacio Hernández-García,
  • Joana Rodríguez-Montolio,
  • Monserrath Almeida-Zurita,
  • Dionisio Cheli-Gracia and ,
  • Belén del Moral Sahuquillo,
  • Carlos Aibar-Remón and
  • Moisés Garcés-Redondo
  • + 2 authors+ 0 author

26 January 2024

Our objective was to know the COVID-19 vaccination coverage in multiple sclerosis (MS) patients and its factors associated. A retrospective cohort study was carried out. Patients seen at the MS unit of the University Clinical Hospital of Zaragoza bet...

(This article belongs to the Special Issue Infectious Diseases: Importance for Public Health, Epidemiology, Promoting Factors, and Vaccines Prevention)
  • Article
  • Open Access
3 Citations
3,320 Views
18 Pages

Optimizing Belantamab Mafodotin in Relapsed or Refractory Multiple Myeloma: Impact of Dose Modifications on Adverse Events and Hematologic Response in a Real-World Retrospective Study

  • Lina Zoe Rüsing,
  • Jakob Schweighofer,
  • Julia Aschauer,
  • Georg Jeryczynski and ,
  • Lea Vospernik,
  • Heinz Gisslinger,
  • Armin Marcus Bumberger,
  • Julia Cserna,
  • Julia Riedl and
  • Maria-Theresa Krauth
  • + 6 authors+ 1 author

19 July 2025

Background: Belantamab mafodotin (belamaf) is a BCMA-targeting antibody–drug conjugate used in triple-class refractory multiple myeloma. Despite its efficacy, keratopathy remains a significant dose-limiting toxicity. Following its withdrawal fr...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Article
  • Open Access
2 Citations
2,500 Views
25 Pages

11 October 2023

Vaccination strategies remain one of the most effective and feasible preventive measures in combating infectious diseases, particularly during the COVID-19 pandemic. With the passage of time, continuous long-term lockdowns became impractical, and the...

(This article belongs to the Special Issue New Challenges in Mathematical Modelling and Control of COVID-19 Epidemics: Analysis of Non-pharmaceutical Actions and Vaccination Strategies)
  • Article
  • Open Access
9 Citations
3,117 Views
14 Pages

Multiple Dosing and Preactivation of Mesenchymal Stromal Cells Enhance Efficacy in Established Pneumonia Induced by Antimicrobial-Resistant Klebsiella pneumoniae in Rodents

  • Declan Byrnes,
  • Claire H. Masterson,
  • Hector E. Gonzales,
  • Sean D. McCarthy and ,
  • Daniel P. O’Toole and
  • John G. Laffey
  • + 1 author+ 0 author

Antimicrobial-resistant (AMR) bacteria, such as Klebsiella species, are an increasingly common cause of hospital-acquired pneumonia, resulting in high mortality and morbidity. Harnessing the host immune response to AMR bacterial infection using mesen...

(This article belongs to the Special Issue Mesenchymal Stromal Cells’ Involvement in Human Diseases and Their Treatment)
  • Article
  • Open Access
23 Citations
4,573 Views
11 Pages

Exposure of Zero-Dose Children to Multiple Deprivation: Analyses of Data from 80 Low- and Middle-Income Countries

  • Andrea Wendt,
  • Thiago M. Santos,
  • Bianca O. Cata-Preta,
  • Luisa Arroyave and ,
  • Daniel R. Hogan,
  • Tewodaj Mengistu,
  • Aluisio J. D. Barros and
  • Cesar G. Victora
  • + 3 authors+ 0 author

19 September 2022

The concept of multiple deprivation recognizes that the same individuals, households, and communities are often exposed to several forms of scarcity. We assessed whether lack of immunization is also associated with nutritional, environmental, and edu...

(This article belongs to the Section Epidemiology and Vaccination)
  • Perspective
  • Open Access
74 Citations
10,648 Views
9 Pages

31 March 2023

Immunization has one of the highest coverage levels of any health intervention, yet there remain zero-dose children, defined as those who do not receive any routine immunizations. There were 18.2 million zero-dose children in 2021, and as they accoun...

(This article belongs to the Special Issue Inequality in Immunization 2023)
  • Article
  • Open Access
342 Views
12 Pages

14 August 2026

Systematic optimization of pediatric brain computed tomography (CT) protocols remains challenging because clinical data are limited for children younger than 5 years. Sixty-nine non-contrast brain CT examinations in children aged 5 years or younger w...

(This article belongs to the Section Medical Imaging)
  • Article
  • Open Access
7 Citations
7,373 Views
15 Pages

Many different quantitative techniques have been developed to either assess Environmental Justice (EJ) issues or estimate exposure and dose for risk assessment. However, very few approaches have been applied to link EJ factors to exposure dose estima...

(This article belongs to the Section Environmental Health)
  • Article
  • Open Access
8 Citations
5,122 Views
19 Pages

17 August 2017

Therapeutic effects of continuous intravenous infusions of solvent-free low doses of resveratrol on organ injury and systemic consequences resulting from severe hemorrhagic shock in rats were studied. Hemorrhagic shock was induced by withdrawing arte...

  • Perspective
  • Open Access
3 Citations
2,052 Views
9 Pages

Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice

  • Ioannis Ntanasis-Stathopoulos,
  • Vassilis Koutoulidis,
  • Panagiotis Malandrakis,
  • Despina Fotiou and ,
  • Vasiliki Spiliopoulou,
  • Charalampos Filippatos,
  • Magdalini Migkou,
  • Nikolaos Kanellias,
  • Foteini Theodorakakou and
  • Maria Gavriatopoulou
  • + 10 authors+ 5 authors

25 March 2025

Smoldering multiple myeloma (SMM) represents an intermediate stage between monoclonal gammopathy of undetermined significance and symptomatic multiple myeloma (MM), with a significant risk of progression. Bone disease is a key feature of MM, often ma...

(This article belongs to the Section Hematology)
  • Article
  • Open Access
5 Citations
4,989 Views
16 Pages

Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World “POWERFUL” Study

  • Evangelos Terpos,
  • Panagiotis Repousis,
  • Chrysavgi Lalayanni,
  • Evdoxia Hatjiharissi and ,
  • Theodora Assimakopoulou,
  • Georgios Vassilopoulos,
  • Anastasia Pouli,
  • Emmanouil Spanoudakis,
  • Eurydiki Michalis and
  • Eirini Katodritou
  • + 17 authors+ 12 authors

5 April 2021

The “POWERFUL” multicenter, retrospective, and prospective study investigated the effectiveness of pomalidomide plus low-dose dexamethasone (POM/LoDex) therapy in relapsed/refractory multiple myeloma in routine care in Greece. Ninety-nine eligible ad...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
615 Views
14 Pages

Impact of Tumor Geometry on Dose Distribution and Delivery Accuracy in Multi-Target Stereotactic Radiosurgery

  • Hsiao-Mei Fu,
  • Tsung-Yu Yen,
  • Chia-Ting Lee,
  • Ko-Hsin Hsiao and ,
  • Yu-Po Shen and
  • Shih-Ming Hsu
  • + 1 author+ 0 author

Objectives: This study aimed to evaluate the influence of tumor geometry on dose distribution and delivery accuracy, and to assess the impact of the Automatic Lower Dose Objective (ALDO) function on dosimetric performance. Methods: Computed tomograph...

(This article belongs to the Section Neuro-oncology)
  • Article
  • Open Access
2 Citations
1,097 Views
7 Pages

1 October 2017

Purpose: We assessed response to treatment, toxicity, time to progression, progression-free survival, and overall survival in patients newly diagnosed with multiple myeloma who were ineligible for or unwilling to undergo transplantation and who were...

of 79